Boston, MA
Alys Pharmaceuticals engages in immuno-dermatology services. The company is reshaping the treatment landscape through advanced scientific innovations and a strong research and development-focused multi-platform pipeline. Alys emerged as a result of the strategic aggregation of 6 asset-centric companies backed by Medicxi.
alyspharma.comThese are collections Alys Pharmaceuticals is a part of. Click on the collection name to view similar companies.
Seed
$100,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Alys Pharmaceuticals.